Therefore, we concluded that the inhibition of LRPAP1 reduced multiple viral infections that were not limited to RNA viruses (coronavirus, enterovirus, flavivirus), but also applied to DNA viruses (herpes virus and hepadnavirus). Here, LRPAP1 is linked to viral infectious disease.